SELLAS Life Sciences Group, Inc. (SLS): Balans kapitallashuviga qarzlar

SELLAS Life Sciences Group (SLS) kompaniyasining korporativ logotipi

SELLAS Life Sciences (SLS) qimmatli qog'ozlarining bozor dinamikasi 0.01 darajasidagi ko'rsatkichlarni namoyish etmoqda. Biznes leykemiyaga qarshi kurashish uchun GPS texnologiyasiga tayanadi va metastazlarga qarshi ilg'or vaksinalarni ishlab chiqmoqda. Shu bilan birga, kompaniya ekologik qoidalarga qat'iy rioya qilgan holda, o'z laboratoriyalarida emissiyalarni minimallashtirmoqda. Firmaning joriy holati tashqi moliyalashtirishga bog'liq, chunki hali daromadli manbalar mavjud emas va dori vositalarini sinovdan o'tkazish jarayonlari hali davom etmoqda.

SELLAS Life Sciences Group Inc. (SLS): Qarzning sof aktivlarga nisbati 04.07.2022dan 27.10.2026gacha

sellaslifesciences.com (SLS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi SELLAS Life Sciences Group|SLS - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi SELLAS Life Sciences|SLS - Korxonaning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar SELLAS Life Sciences|SLS - Kompaniyaning buxgalteriya qiymati|Kapitallashuvning sof aktivlarga nisbati sellaslifesciences.com|SLS - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati SELLAS Life Sciences|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati SELLAS Life Sciences Group|SLS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati SELLAS Life Sciences
Kompaniyaning jamlanma tahliliyoti:SLS, SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group, Inc. tomonidan chiqariladigan mahsulotlar

Ushbu koeffitsiyent kompaniyaning o'z kapital qiymatiga nisbatan tashqi qarzlarga bog'liqligini o'lchaydi va uning moliyaviy barqarorligini boshqarish samaradorligini aks ettiradi. O'zining tijorat mahsulotlarisiz, grantlar va sherikliklar orqali faoliyat yurituvchi SELLAS Life Sciences (SLS) uchun moliyaviy majburiyatlar va kitob kapitalizatsiyasi o'rtasidagi korrelyatsiya, rahbariyatning immunoterapiya dori vositalarini ishlab chiqishni kritik qarz yuklamasisiz moliyalashtirish qobiliyatini namoyish etadi.

SELLAS Life Sciences raqobatchilari

BeiGene Ltd - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD (Revolution Medicines, Inc.) - Balans kapitallashuviga qarzlar|AAPG: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati CG Oncology Corp CGON|Qarzning sof aktivlarga nisbati UroGen Pharma Corp|BCAX - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati personalis.com|Balans kapitallashuviga qarzlar ERAS (Erasca)|Qarzning balans qiymatiga nisbati Delcath Systems Inc DCTH|Qarzning balans qiymatiga nisbati YMAB (YmAbs)|Aura Corp - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Candel (CADL)|ARAY - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ACTU|CTOR (Citius Oncology Inc.) - Balans qiymatiga qarzlar|HURA: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Protara Tx|Fate Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar WHWK (aadibio.com)|Qarzning balans kapitallashuviga nisbati TScan Therapeutics, Inc. TCRX|Champions Oncology Inc - Qarzning balans kapitallashuviga nisbati|XBIT - Qarzning balans kapitallashuviga nisbati|CVM - Qarzning balans kapitallashuviga nisbati|OSTX: Balans kapitallashuviga qarzlar|RADX (radiopharmtheranostics.com) - Balans kapitallashuviga qarzlar|ARTV: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Adlai Nortye Limited (ANL)|Veru Pharma (VERU) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati TPST (Tempest Therapeutics Corp)|Qarzning balans kapitallashuviga nisbati Xilio Therapeutics XLO|Qarzning balans kapitallashuviga nisbati Renovaro Biosciences RENB|Balans kapitallashuviga qarzlar MURA (Mural Bio)|KAPA - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar onkuretherapeutics.com (OKUR)|CytoMed Therapeutics Limited (GDTC) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar CRIS (Curis Inc.)|Balans qiymatiga qarzlar Apollomics Corp (APLM)|Tharimmune (THAR) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ADVB (advanbiomed.com)|Qarzning balans kapitallashuviga nisbati GNPX|Sof aktivlarga qarzlar Calidi Biotherapeutics Inc. CLDI|SBFM: Balans kapitallashuviga qarzlar|XBIO - Qarzning balans qiymatiga nisbati|Salarius Pharmaceuticals, Inc. - Balans kapitallashuviga qarzlar|Purple Biotech Ltd (PPBT) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar AONC (American Oncology Network Inc)|Balans qiymatiga qarzlar BGNE|Qarzning balans kapitallashuviga nisbati Checkpoint Therapeutics CKPT|Qarzning balans qiymatiga nisbati elevationoncology.com (ELEV)|iCAD - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Ikena Oncology Inc. IKNA|NTBL (Notable Labs Inc.) - Balans kapitallashuviga qarzlar|VIRX: Balans qiymatiga qarzlar|MorphoSys AG - Qarzning balans kapitallashuviga nisbati|NAYA (nayabiosciences.com) - Sof aktivlarga qarzlar|AAPGV: Qarzning balans kapitallashuviga nisbati